BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 26493683)

  • 21. The mechanism accounting for DNA damage strength modulation of p53 dynamical properties.
    Ma A; Dai X
    J Bioinform Comput Biol; 2023 Jun; 21(3):2350011. PubMed ID: 37325863
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Switch in p53 Dynamics Marks Cells That Escape from DSB-Induced Cell Cycle Arrest.
    Tsabar M; Mock CS; Venkatachalam V; Reyes J; Karhohs KW; Oliver TG; Regev A; Jambhekar A; Lahav G
    Cell Rep; 2020 Aug; 32(5):107995. PubMed ID: 32755587
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dynamics of the p53-Mdm2 feedback loop in individual cells.
    Lahav G; Rosenfeld N; Sigal A; Geva-Zatorsky N; Levine AJ; Elowitz MB; Alon U
    Nat Genet; 2004 Feb; 36(2):147-50. PubMed ID: 14730303
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LRRK2 interacts with ATM and regulates Mdm2-p53 cell proliferation axis in response to genotoxic stress.
    Chen Z; Cao Z; Zhang W; Gu M; Zhou ZD; Li B; Li J; Tan EK; Zeng L
    Hum Mol Genet; 2017 Nov; 26(22):4494-4505. PubMed ID: 28973420
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exploring a minimal two-component p53 model.
    Sun T; Yuan R; Xu W; Zhu F; Shen P
    Phys Biol; 2010 Sep; 7(3):036008. PubMed ID: 20834108
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oscillatory Dynamics of p53 Genetic Network Induced by Feedback Loops and Time Delays.
    Wang C; Liu H; Zhou J
    IEEE Trans Nanobioscience; 2019 Oct; 18(4):611-621. PubMed ID: 31226080
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Caspase 2 and p53 Reunited in Tumor Control.
    Petroni G; Vitale I; Galluzzi L
    Trends Cell Biol; 2020 Dec; 30(12):917-918. PubMed ID: 32921524
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mathematical modeling of functioning of the p53-Mdm2 protein system.
    Voropaeva OF; Shokin YI; Nepomnyashchikh LM; Senchukova SR
    Bull Exp Biol Med; 2014 Jun; 157(2):291-4. PubMed ID: 24952502
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of MDM2 Stability After DNA Damage.
    Li J; Kurokawa M
    J Cell Physiol; 2015 Oct; 230(10):2318-27. PubMed ID: 25808808
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TRIAD1 inhibits MDM2-mediated p53 ubiquitination and degradation.
    Bae S; Jung JH; Kim K; An IS; Kim SY; Lee JH; Park IC; Jin YW; Lee SJ; An S
    FEBS Lett; 2012 Sep; 586(19):3057-63. PubMed ID: 22819825
    [TBL] [Abstract][Full Text] [Related]  

  • 31. From structure to dynamics: frequency tuning in the p53-Mdm2 network I. Logical approach.
    Abou-Jaoudé W; Ouattara DA; Kaufman M
    J Theor Biol; 2009 Jun; 258(4):561-77. PubMed ID: 19233211
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A cross-nearest neighbor/Monte Carlo algorithm for single-molecule localization microscopy defines interactions between p53, Mdm2, and MEG3.
    Bauer NC; Yang A; Wang X; Zhou Y; Klibanski A; Soberman RJ
    J Biol Chem; 2021; 296():100540. PubMed ID: 33722609
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential response between the p53 ubiquitin-protein ligases Pirh2 and MdM2 following DNA damage in human cancer cells.
    Duan W; Gao L; Wu X; Zhang Y; Otterson GA; Villalona-Calero MA
    Exp Cell Res; 2006 Oct; 312(17):3370-8. PubMed ID: 16934800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Frequency domain analysis reveals external periodic fluctuations can generate sustained p53 oscillation.
    Shin YJ; Hencey B; Lipkin SM; Shen X
    PLoS One; 2011; 6(7):e22852. PubMed ID: 21829536
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mdm2 selectively suppresses DNA damage arising from inhibition of topoisomerase II independent of p53.
    Senturk JC; Bohlman S; Manfredi JJ
    Oncogene; 2017 Nov; 36(44):6085-6096. PubMed ID: 28692049
    [TBL] [Abstract][Full Text] [Related]  

  • 36. p53 modulation of the DNA damage response.
    Helton ES; Chen X
    J Cell Biochem; 2007 Mar; 100(4):883-96. PubMed ID: 17031865
    [TBL] [Abstract][Full Text] [Related]  

  • 37. p53 mRNA and p53 Protein Structures Have Evolved Independently to Interact with MDM2.
    Karakostis K; Ponnuswamy A; Fusée LT; Bailly X; Laguerre L; Worall E; Vojtesek B; Nylander K; Fåhraeus R
    Mol Biol Evol; 2016 May; 33(5):1280-92. PubMed ID: 26823446
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mdm2: p53's lifesaver?
    Shmueli A; Oren M
    Mol Cell; 2007 Mar; 25(6):794-6. PubMed ID: 17386256
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PI3K/AKT and Mdm2 activation are associated with inhibitory effect of cAMP increasing agents on DNA damage-induced cell death in human pre-B NALM-6 cells.
    Ghorbani A; Jeddi-Tehrani M; Saidpour A; Safa M; Bayat AA; Zand H
    Arch Biochem Biophys; 2015 Jan; 566():58-66. PubMed ID: 25524737
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The p53 mRNA-Mdm2 interaction controls Mdm2 nuclear trafficking and is required for p53 activation following DNA damage.
    Gajjar M; Candeias MM; Malbert-Colas L; Mazars A; Fujita J; Olivares-Illana V; Fåhraeus R
    Cancer Cell; 2012 Jan; 21(1):25-35. PubMed ID: 22264786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.